Appliedvr recalls RelieVR REF: RVX-2002, Rx Only. Virtual reality behavioral therapy device for pain relief.

Recall date

February 27, 2023

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

Z-2044-2023

FDA classification

Class II

Brand / firm

Appliedvr

Sold / distributed

US: NY OUS: None

Why it was recalled

There is the potential for the program software to malfunction which will not allow it to move forward to the next session.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

RelieVR REF: RVX-2002, Rx Only. Virtual reality behavioral therapy device for pain relief.